Long-Term Immunological and Functional Effects of Adenoviral-Mediated Ctla4-Ig Gene Transfer into Pancreatic Allografts
C Liu,S Deng,F Gao,F Chen,W Liu,A Shaked,KL Brayman
DOI: https://doi.org/10.1097/00007890-199905150-00139
1999-01-01
Transplantation
Abstract:114 Introduction T cell activation is a two-step process depending on both T cell receptor activation and co-stimulation through the CD28 receptor. CTLA4-Ig blocks the CD28 co-stimulation pathway, and hence leads to a state of T cell anergy. We have previously reported that AdCTLA-4Ig infection of allografts prior to transplantation results in localized gene expression which leads to prolonged graft survival and donor-specific tolerance. In this study, we examined the long term consequences of graft residence following gene transfer and co-stimulatory blockade by 1) challenging established grafts with donor-specific alloantigen (skin) and 2) retransplantation of established grafts to assess graft specific changes following in vivo residence in the MHC-incompatible host,. Methods Only long-term pancreatic allograft survivors (>1 year) with normal pancreatic function were used in this study. Pancreas allograft function was determined by blood glucose level and IVGTT. CTLA4-Ig gene expression was not detectable in recipients after 3 months (FACS, PCR) following transplantation. Donor-specific skin allograft transplantation to normoglycemic pancreas allograft recipients was performed to determine the integrity and stability of the tolerance state. Pancreas allograft retransplantation was also done to examine the long-term effect of gene transfer and graft residence on pancreatic function and graft chimerism. Results Control Lewis skin (to normal Wistar Furth recipients, n=5) survived on average 9 days. Transplantation of Lewis skin to long-term survival pancreatic allograft recipients (Lewis to WF) gave a mean survival time more than 100 days (n=6, p<0.01), indicating stable recipient tolerance. Skin allograft recipients remained normoglycemic following donor-specific allo-antigen challenge. To further determine the long-term effect of gene transfer and graft residence, re-transplantation of pancreatic allografts was performed. Re-transplantation of long-term survival allografts re-transplanted to donor-specific strain recipients (Lewis >WF to Lewis) resulted in indefinite graft survival (>100 days, n=4). In contrast, allografts retransplanted to recipient strain animals (W/F) survived an average of 14 days (Lewis > WF to WF, n=4), slightly less but not significantly different from the control (Lewis to WF, MST=17 days, n=6). However, when retransplantation to recipient strain animals was performed one day after low dose (200 rad) radiation of the recipient, the mean survival time was prolonged (MST=42.3 days, n=4), a significant difference compared to controls (Lewis to W/F, 200 rad., MST=30 days, n=4, P<0.05). Conclusion Adenoviral-mediated CTLA4-Ig gene transfer into pancreatic allografts produces long-term graft survival (>1 year) and stable donor-specific tolerance. Retransplantation of established grafts, combined with low dose radiation treatment of the recipient results in modest prolongation of graft survival, suggesting modest alteration of graft immuno-genicity after prolonged residence.